{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:14:10Z","timestamp":1793711650081,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The immunologic consequences of using bactericidal versus bacteriostatic antibiotic treatments are unclear. We observed a bacteriostatic (growth halting) treatment was more protective than a bactericidal (bacteria killing) treatment in a murine peritonitis model. To understand this unexpected difference, we compared macrophage responses to bactericidal treated bacteria or bacteriostatic treated bacteria. We found that Gram-negative bacteria treated with bactericidal drugs induced more proinflammatory cytokines than those treated with bacteriostatic agents. Bacterial DNA \u2013 released only by bactericidal treatments \u2013 exacerbated inflammatory signaling through TLR9. Without TLR9 signaling, the in vivo efficacy of bactericidal drug treatment was rescued. This demonstrates that antibiotics can act in important ways distinct from bacterial inhibition: like causing treatment failure by releasing DNA that induces excessive inflammation. These data establish a novel link between how an antibiotic affects bacterial physiology and subsequent immune system engagement, which may be relevant for optimizing treatments to simultaneously clear bacteria and modulate inflammation.<\/jats:p>","DOI":"10.1038\/s41467-024-54497-3","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T12:21:27Z","timestamp":1732796487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Bactericidal antibiotic treatment induces damaging inflammation via TLR9 sensing of bacterial DNA"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-7258","authenticated-orcid":false,"given":"Julia L.","family":"Gross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6410-3517","authenticated-orcid":false,"given":"Clinton J.","family":"Bradfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinu P.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3701-5228","authenticated-orcid":false,"given":"John P.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0980-7866","authenticated-orcid":false,"given":"David S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2272-3907","authenticated-orcid":false,"given":"Iain D. C.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"54497_CR1","unstructured":"Outpatient Antibiotic Prescriptions \u2014 United States, 2022 | Antibiotic Use | CDC. https:\/\/www.cdc.gov\/antibiotic-use\/data\/report-2022.html (2023)."},{"key":"54497_CR2","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.tim.2017.07.005","volume":"25","author":"BR Levin","year":"2017","unstructured":"Levin, B. R., Baquero, F., Ankomah, P., (Pierre) & McCall, I. C. Phagocytes, antibiotics, and self-limiting bacterial infections. Trends Microbiol. 25, 878\u2013892 (2017).","journal-title":"Trends Microbiol."},{"key":"54497_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1074-7613(00)80004-7","volume":"10","author":"MU Shiloh","year":"1999","unstructured":"Shiloh, M. U. et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10, 29\u201338 (1999).","journal-title":"Immunity"},{"key":"54497_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.tips.2017.02.003","volume":"38","author":"J Munguia","year":"2017","unstructured":"Munguia, J. & Nizet, V. Pharmacological targeting of the host\u2013pathogen interaction: alternatives to classical antibiotics to combat drug-resistant superbugs. Trends Pharmacol. Sci. 38, 473\u2013488 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"54497_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1189\/jlb.4MR0316-153RR","volume":"101","author":"AJ Wolf","year":"2017","unstructured":"Wolf, A. J., Liu, G. Y. & Underhill, D. M. Inflammatory properties of antibiotic-treated bacteria. J. Leukoc. Biol. 101, 127\u2013134 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"54497_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41564-020-0763-4","volume":"5","author":"HB Park","year":"2020","unstructured":"Park, H. B. et al. Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli. Nat. Microbiol. 5, 1319\u20131329 (2020).","journal-title":"Nat. Microbiol."},{"key":"54497_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00109-013-1100-7","volume":"92","author":"G Sakoulas","year":"2014","unstructured":"Sakoulas, G. et al. Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus. J. Mol. Med. 92, 139\u2013149 (2014).","journal-title":"J. Mol. Med."},{"key":"54497_CR8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","volume":"2","author":"L Lin","year":"2015","unstructured":"Lin, L. et al. Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens. EBioMedicine 2, 690\u2013698 (2015).","journal-title":"EBioMedicine"},{"key":"54497_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.chom.2017.10.020","volume":"22","author":"JH Yang","year":"2017","unstructured":"Yang, J. H. et al. Antibiotic-induced changes to the host metabolic environment inhibit drug efficacy and alter immune function. Cell Host Microbe 22, 757\u2013765.e3 (2017).","journal-title":"Cell Host Microbe"},{"key":"54497_CR10","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.1128\/mBio.00021-13","volume":"4","author":"BA Napier","year":"2013","unstructured":"Napier, B. A. et al. Clinical use of colistin induces cross-resistance to host antimicrobials in acinetobacter baumannii. mBio 4, e00021\u201313 (2013).","journal-title":"mBio"},{"key":"54497_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.cell.2018.01.021","volume":"172","author":"Y Kawai","year":"2018","unstructured":"Kawai, Y., Mickiewicz, K. & Errington, J. Lysozyme counteracts \u03b2-lactam antibiotics by promoting the emergence of L-form bacteria. Cell 172, 1038\u20131049.e10 (2018).","journal-title":"Cell"},{"key":"54497_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature07250","volume":"455","author":"K Brandl","year":"2008","unstructured":"Brandl, K. et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455, 804\u2013807 (2008).","journal-title":"Nature"},{"key":"54497_CR13","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1128\/AAC.02432-14","volume":"58","author":"BA Napier","year":"2014","unstructured":"Napier, B. A., Band, V., Burd, E. M. & Weiss, D. S. Colistin heteroresistance in enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob. Agents Chemother. 58, 5594\u20135597 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"54497_CR14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1086\/381972","volume":"38","author":"GA Pankey","year":"2004","unstructured":"Pankey, G. A. & Sabath, L. D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin. Infect. Dis. 38, 864\u2013870 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"54497_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/jac\/dku379","volume":"70","author":"J Nemeth","year":"2015","unstructured":"Nemeth, J., Oesch, G. & Kuster, S. P. Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis. J. Antimicrob. Chemother. 70, 382\u2013395 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"54497_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev.bi.52.070183.004141","volume":"52","author":"DJ Waxman","year":"1983","unstructured":"Waxman, D. J. & Strominger, J. L. Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics. Annu. Rev. Biochem. 52, 825\u2013869 (1983).","journal-title":"Annu. Rev. Biochem."},{"key":"54497_CR17","doi-asserted-by":"publisher","first-page":"a025247","DOI":"10.1101\/cshperspect.a025247","volume":"6","author":"K Bush","year":"2016","unstructured":"Bush, K. & Bradford, P. A. \u03b2-lactams and \u03b2-lactamase inhibitors: an overview. Cold Spring Harb. Perspect. Med. 6, a025247 (2016).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"54497_CR18","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1086\/314056","volume":"31","author":"DC Hooper","year":"2000","unstructured":"Hooper, D. C. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis. 31, S24\u2013S28 (2000).","journal-title":"Clin. Infect. Dis."},{"key":"54497_CR19","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"KJ Aldred","year":"2014","unstructured":"Aldred, K. J., Kerns, R. J. & Osheroff, N. Mechanism of quinolone action and resistance. Biochemistry 53, 1565\u20131574 (2014).","journal-title":"Biochemistry"},{"key":"54497_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"I Chopra","year":"2001","unstructured":"Chopra, I. & Roberts, M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65, 232\u2013260 (2001).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"54497_CR21","doi-asserted-by":"publisher","first-page":"a025387","DOI":"10.1101\/cshperspect.a025387","volume":"6","author":"TH Grossman","year":"2016","unstructured":"Grossman, T. H. Tetracycline antibiotics and resistance. Cold Spring Harb. Perspect. Med. 6, a025387 (2016).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"54497_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0031-3955(16)32088-0","volume":"15","author":"D Ingall","year":"1968","unstructured":"Ingall, D. & Sherman, J. D. Chloramphenicol. Pediatr. Clin. North Am. 15, 57\u201372 (1968).","journal-title":"Pediatr. Clin. North Am."},{"key":"54497_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev.bb.20.060191.002051","volume":"20","author":"WV Shaw","year":"1991","unstructured":"Shaw, W. V. & Leslie, A. G. W. Chloramphenicol acetyltransferase. Annu. Rev. Biophys. Biophys. Chem. 20, 363\u2013386 (1991).","journal-title":"Annu. Rev. Biophys. Biophys. Chem."},{"key":"54497_CR24","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1073\/pnas.73.10.3386","volume":"73","author":"P Herrlich","year":"1976","unstructured":"Herrlich, P. & Schweiger, M. Nitrofurans, a group of synthetic antibiotics, with a new mode of action: discrimination of specific messenger RNA classes. Proc. Natl Acad. Sci. Usa. 73, 3386\u20133390 (1976).","journal-title":"Proc. Natl Acad. Sci. Usa."},{"key":"54497_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/jac\/33.suppl_A.23","volume":"33","author":"CC McOsker","year":"1994","unstructured":"McOsker, C. C. & Fitzpatrick, P. M. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J. Antimicrob. Chemother. 33, 23\u201330 (1994).","journal-title":"J. Antimicrob. Chemother."},{"key":"54497_CR26","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1093\/jac\/dkw212","volume":"71","author":"F Fransen","year":"2016","unstructured":"Fransen, F., Melchers, M. J. B., Meletiadis, J. & Mouton, J. W. Pharmacodynamics and differential activity of nitrofurantoin against ESBL-positive pathogens involved in urinary tract infections. J. Antimicrob. Chemother. 71, 2883\u20132889 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"54497_CR27","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1093\/jac\/dky255","volume":"73","author":"RA Wijma","year":"2018","unstructured":"Wijma, R. A., Huttner, A., Koch, B. C. P., Mouton, J. W. & Muller, A. E. Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline. J. Antimicrob. Chemother. 73, 2916\u20132926 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"54497_CR28","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/cid\/cix1127","volume":"66","author":"N Wald-Dickler","year":"2018","unstructured":"Wald-Dickler, N., Holtom, P. & Spellberg, B. Busting the Myth of \u201cStatic vs Cidal\u201d: a systemic literature review. Clin. Infect. Dis. 66, 1470\u20131474 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"54497_CR29","doi-asserted-by":"publisher","unstructured":"McDonald, D. R. & Levy, O. Innate immunity. in Clinical Immunology 35\u201346 (Elsevier, 2013). https:\/\/doi.org\/10.1016\/B978-0-7234-3691-1.00027-1.","DOI":"10.1016\/B978-0-7234-3691-1.00027-1"},{"key":"54497_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-0901-5_1","volume":"653","author":"S Mukhopadhyay","year":"2009","unstructured":"Mukhopadhyay, S., Pl\u00fcddemann, A. & Gordon, S. Macrophage pattern recognition receptors in immunity, homeostasis and self tolerance. Adv. Exp. Med. Biol. 653, 1\u201314 (2009).","journal-title":"Adv. Exp. Med. Biol."},{"key":"54497_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway","year":"2002","unstructured":"Janeway, C. A. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197\u2013216 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"54497_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/41131","volume":"388","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394\u2013397 (1997).","journal-title":"Nature"},{"key":"54497_CR33","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1126\/science.285.5428.736","volume":"285","author":"AO Aliprantis","year":"1999","unstructured":"Aliprantis, A. O. et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736\u2013739 (1999).","journal-title":"Science"},{"key":"54497_CR34","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1126\/science.285.5428.732","volume":"285","author":"HD Brightbill","year":"1999","unstructured":"Brightbill, H. D. et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285, 732\u2013736 (1999).","journal-title":"Science"},{"key":"54497_CR35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099\u20131103 (2001).","journal-title":"Nature"},{"key":"54497_CR36","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740\u2013745 (2000).","journal-title":"Nature"},{"key":"54497_CR37","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805\u2013820 (2010).","journal-title":"Cell"},{"key":"54497_CR38","doi-asserted-by":"crossref","unstructured":"Kawasaki, T. & Kawai, T. Toll-like receptor signaling pathways. Front. Immunol. 5, (2014).","DOI":"10.3389\/fimmu.2014.00461"},{"key":"54497_CR39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.cels.2016.04.016","volume":"2","author":"RA Gottschalk","year":"2016","unstructured":"Gottschalk, R. A. et al. Distinct NF-\u03baB and MAPK activation thresholds uncouple steady-state microbe sensing from anti-pathogen inflammatory responses. Cell Syst. 2, 378\u2013390 (2016).","journal-title":"Cell Syst."},{"key":"54497_CR40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.46836","volume":"8","author":"RA Gottschalk","year":"2019","unstructured":"Gottschalk, R. A. et al. IFN-mediated negative feedback supports bacteria class-specific macrophage inflammatory responses. eLife 8, e46836 (2019).","journal-title":"eLife"},{"key":"54497_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cels.2019.02.008","volume":"8","author":"K Lane","year":"2019","unstructured":"Lane, K., Andres-Terre, M., Kudo, T., Monack, D. M. & Covert, M. W. Escalating threat levels of bacterial infection can be discriminated by distinct MAPK and NF-\u03baB signaling dynamics in single host cells. Cell Syst. 8, 183\u2013196.e4 (2019).","journal-title":"Cell Syst."},{"key":"54497_CR42","unstructured":"Macrobid \u00ae (nitrofurantoin monohydrate\/macrocrystals) [Package Insert]. (2009)."},{"key":"54497_CR43","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. (2024)."},{"key":"54497_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.idc.2004.04.012","volume":"18","author":"ME Levison","year":"2004","unstructured":"Levison, M. E. Pharmacodynamics of antimicrobial drugs. Infect. Dis. Clin. North Am. 18, 451\u2013465 (2004).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"54497_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1469-0691.2000.00058-2.x","volume":"6","author":"BA Cunha","year":"2000","unstructured":"Cunha, B. A., Domenico, P. & Cunha, C. B. Pharmacodynamics of doxycycline. Clin. Microbiol. Infect. 6, 270\u2013273 (2000).","journal-title":"Clin. Microbiol. Infect."},{"key":"54497_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature06726","volume":"452","author":"Y-M Kim","year":"2008","unstructured":"Kim, Y.-M., Brinkmann, M. M., Paquet, M.-E. & Ploegh, H. L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452, 234\u2013238 (2008).","journal-title":"Nature"},{"key":"54497_CR47","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41586-019-1611-7","volume":"575","author":"O Majer","year":"2019","unstructured":"Majer, O. et al. Release from Unc93b1 reinforces the compartmentalized activation of select TLRs. Nature 575, 371\u2013374 (2019).","journal-title":"Nature"},{"key":"54497_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0732-8893(93)90109-K","volume":"16","author":"RHK Eng","year":"1993","unstructured":"Eng, R. H. K., Smith, S. M., Fan-Havard, P. & Ogbara, T. Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn. Microbiol. Infect. Dis. 16, 185\u2013189 (1993).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"54497_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1099\/00222615-40-1-23","volume":"40","author":"HA Crosby","year":"1994","unstructured":"Crosby, H. A., Bion, J. F., Penn, C. W. & Elliott, T. S. J. Antibiotic-induced release of endotoxin from bacteria in vitro. J. Med. Microbiol. 40, 23\u201330 (1994).","journal-title":"J. Med. Microbiol."},{"key":"54497_CR50","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/iai.59.2.689-695.1991","volume":"59","author":"I Mattsby-Baltzer","year":"1991","unstructured":"Mattsby-Baltzer, I., Lindgren, K., Lindholm, B. & Edebo, L. Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity. Infect. Immun. 59, 689\u2013695 (1991).","journal-title":"Infect. Immun."},{"key":"54497_CR51","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3109\/00365549109024303","volume":"23","author":"ASM Dofferhoff","year":"1991","unstructured":"Dofferhoff, A. S. M. et al. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand. J. Infect. Dis. 23, 745\u2013754 (1991).","journal-title":"Scand. J. Infect. Dis."},{"key":"54497_CR52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221086","volume":"220","author":"KA Lacey","year":"2023","unstructured":"Lacey, K. A. et al. Secreted mammalian DNases protect against systemic bacterial infection by digesting biofilms. J. Exp. Med. 220, e20221086 (2023).","journal-title":"J. Exp. Med."},{"key":"54497_CR53","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1084\/jem.20080162","volume":"205","author":"G Plitas","year":"2008","unstructured":"Plitas, G., Burt, B. M., Nguyen, H. M., Bamboat, Z. M. & DeMatteo, R. P. Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J. Exp. Med. 205, 1277\u20131283 (2008).","journal-title":"J. Exp. Med."},{"key":"54497_CR54","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1111\/bph.14494","volume":"175","author":"J Garrido-Mesa","year":"2018","unstructured":"Garrido-Mesa, J. et al. Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution. Br. J. Pharmacol. 175, 4353\u20134370 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"54497_CR55","doi-asserted-by":"crossref","unstructured":"Cola\u00e7o, H. G. et al. Tetracycline antibiotics induce host-dependent disease tolerance to infection. Immunity 54, 53\u201367 (2021).","DOI":"10.1016\/j.immuni.2020.09.011"},{"key":"54497_CR56","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s10753-020-01188-y","volume":"43","author":"A Patel","year":"2020","unstructured":"Patel, A., Khande, H., Periasamy, H. & Mokale, S. Immunomodulatory effect of doxycycline ameliorates systemic and pulmonary inflammation in a murine polymicrobial sepsis model. Inflammation 43, 1035\u20131043 (2020).","journal-title":"Inflammation"},{"key":"54497_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03909-1","volume":"26","author":"A Sauer","year":"2022","unstructured":"Sauer, A., Putensen, C. & Bode, C. Immunomodulation by tetracyclines in the critically Ill: an emerging treatment option? Crit. Care 26, 74 (2022).","journal-title":"Crit. Care"},{"key":"54497_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/pmic.201000273","volume":"11","author":"CR Dunston","year":"2011","unstructured":"Dunston, C. R., Griffiths, H. R., Lambert, P. A., Staddon, S. & Vernallis, A. B. Proteomic analysis of the anti-inflammatory action of minocycline. Proteomics 11, 42\u201351 (2011).","journal-title":"Proteomics"},{"key":"54497_CR59","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s13105-015-0448-2","volume":"71","author":"L Bonjoch","year":"2015","unstructured":"Bonjoch, L., Gea-Sorl\u00ed, S., Jordan, J. & Closa, D. Minocycline inhibits peritoneal macrophages but activates alveolar macrophages in acute pancreatitis. J. Physiol. Biochem. 71, 839\u2013846 (2015).","journal-title":"J. Physiol. Biochem."},{"key":"54497_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1590\/S1516-31802007000400009","volume":"125","author":"DD Cicarelli","year":"2007","unstructured":"Cicarelli, D. D., Vieira, J. E. & Bense\u00f1or, F. E. M. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med. J. Rev. Paul. Med. 125, 237\u2013241 (2007).","journal-title":"Sao Paulo Med. J. Rev. Paul. Med."},{"key":"54497_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-1-7","volume":"1","author":"D Annane","year":"2011","unstructured":"Annane, D. Corticosteroids for severe sepsis: an evidence-based guide for physicians. Ann. Intensive Care 1, 7 (2011).","journal-title":"Ann. Intensive Care"},{"key":"54497_CR62","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","volume":"179","author":"F Fang","year":"2019","unstructured":"Fang, F. et al. Association of corticosteroid treatment with outcomes in adult patients with sepsis. JAMA Intern. Med. 179, 213\u2013223 (2019).","journal-title":"JAMA Intern. Med."},{"key":"54497_CR63","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1017\/S0031182000075351","volume":"105","author":"RM Maizels","year":"1992","unstructured":"Maizels, R. M. & Denham, D. A. Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug. Parasitology 105, S49\u2013S60 (1992).","journal-title":"Parasitology"},{"key":"54497_CR64","unstructured":"CDC. Clinical Treatment of Loiasis. Filarial Worms https:\/\/www.cdc.gov\/filarial-worms\/hcp\/clinical-care\/loiasis.html (2024)."},{"key":"54497_CR65","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0169-4758(96)40006-0","volume":"12","author":"JP Chippaux","year":"1996","unstructured":"Chippaux, J. P., Boussinesq, M., Gardon, J., Gardon-Wendel, N. & Ernould, J. C. Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitol. Today Pers. Ed. 12, 448\u2013450 (1996).","journal-title":"Parasitol. Today Pers. Ed."},{"key":"54497_CR66","first-page":"41","volume":"13","author":"R Dieki","year":"2022","unstructured":"Dieki, R., Nsi-Emvo, E. & Akue, J. P. The human filaria loa loa: update on diagnostics and immune response. Res. Rep. Trop. Med. 13, 41\u201354 (2022).","journal-title":"Res. Rep. Trop. Med."},{"key":"54497_CR67","doi-asserted-by":"publisher","unstructured":"Carme, B., Boulesteix, J., Boutes, H. & Puruehnce, M. F. Five Cases of Encephalitis during Treatment of Loiasis with Diethylcarbamazine. https:\/\/doi.org\/10.4269\/ajtmh.1991.44.684 (1991).","DOI":"10.4269\/ajtmh.1991.44.684"},{"key":"54497_CR68","doi-asserted-by":"publisher","unstructured":"Cardona Gloria, Y., Latz, E. & De Nardo, D. Generation of Innate Immune Reporter Cells Using Retroviral Transduction. in Innate Immune Activation: Methods and Protocols (eds. De Nardo, D. & De Nardo, C. M.) 97\u2013117 (Springer, New York, NY, 2018). https:\/\/doi.org\/10.1007\/978-1-4939-7519-8_7.","DOI":"10.1007\/978-1-4939-7519-8_7"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54497-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54497-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54497-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T14:02:09Z","timestamp":1732802529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54497-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54497"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54497-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10359"}}